The Society of Hospital Pharmacists of Australia today congratulated the Tasmanian State Government on its support for hospital pharmacy in the 2016 State Budget.
SHPA CEO Kristin Michaels says the Budget announcement by Minister for Health Michael Ferguson paved the way for the Royal Hobart Hospital to provide enhanced patient care by providing high quality pharmaceutical and chemotherapy manufacturing.
“The provision of $3.7 million in the State Budget for the development of pharmacy at the Royal Hobart Hospital is a critical initiative that will support better outcomes for patients,” Michaels says.
“The Tasmanian State Government’s Budget provision will pave the way for best practice hospital pharmacy through enhanced medicines production and patient management.
“There will be a robust return on this investment because the Pharmacy Department at the Royal Hobart Hospital provides medication for over 1,000 patients each day, including patients from other centres,” Michaels says.
Duncan McKenzie, Pharmacy Manager at the Royal Hobart Hospital, and Chair of the Tasmanian Branch of the SHPA says the Budget initiatives will provide a welcome boost to the quality use of medicines.
“The State Government has been very forward thinking by including a Budget provision that will create a more efficient pharmacy workspace and provide direct access for patients with special and complex medicines requirements,” McKenzie says.
“Hospital pharmacists often have to prepare special products for individual patient requirements, instead of just dispensing already prepared medications, and this requires appropriate facilities.
“The new funding for the Royal Hobart Hospital, includes provision for an improved sterile pharmaceutical production facility,” he says.
“The Budget also provides funds for upgrading the cytotoxic drug manufacturing facility and this is an important staff and patient safety initiative.
“Cytotoxic drugs are not only used for the treatment of cancers but also for the treatment of other medical conditions such as multiple sclerosis and psoriasis.
“The funds provided by the State Government recognise the critical role of pharmacy in ensuring quality health care for hospital patients,” McKenzie says.